PAVmed Income Statement (2022-2025) | PAVM

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.19M0.08M0.11M0.45M0.17M0.79M1.05M1.01M0.98M0.01M0.01M0.01M0.01M
Cost of Revenue 3.92M4.90M4.74M5.76M4.54M4.34M4.02M4.69M4.31M4.24M0.04M0.15M0.25M0.22M0.20M
Gross Profit -0.18M-4.66M-5.65M-4.09M-4.17M-3.23M-3.64M-3.30M-3.26M-0.14M-0.24M-0.21M-0.20M
Operating items
Amortization - Intangibles 0.12M0.65M0.51M0.51M0.51M0.51M0.51M0.51M0.37M0.10M
Research & Development 5.93M6.74M6.20M6.67M4.05M3.47M3.16M3.60M1.94M1.64M0.81M0.79M0.79M1.09M
Selling, General & Administrative 9.47M11.20M10.37M10.16M10.41M6.65M6.86M7.03M6.68M7.01M4.19M4.38M3.67M3.50M
Other Operating Expenses -17.13M5.55M6.87M7.88M1.00M6.43M6.01M0.20M0.28M0.26M0.26M
Operating Expenses 19.82M23.48M23.44M24.71M20.85M16.65M16.32M17.43M15.05M14.66M5.20M5.45M4.72M4.85M
Operating Income -19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M
EBIT -19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M
Non-operating items
Other Non Operating Income 0.00M-5.62M-6.57M0.03M-1.81M-0.26M-6.22M-1.02M0.20M0.25M0.06M
Non Operating Income 0.00M-5.62M-6.57M0.03M-1.81M-1.41M-6.22M-1.02M-4.48M-1.23M6.33M24.07M-7.61M-1.17M
Net income details
EBT -19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M
Profit After Tax -19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.43M18.97M-12.32M-6.01M
Equity Income 0.12M21.00M-10.64M-4.38M
Income from Non-Controlling Interests -2.76M-3.58M-3.81M-4.11M-4.28M-3.35M-4.08M-3.37M-3.30M-4.09M-0.29M-0.34M-0.40M-0.63M
Income from Continuing Operations -19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M
Consolidated Net Income -19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M
Income towards Parent Company -19.63M-29.10M-29.93M-24.57M-22.21M-17.89M-21.75M-17.41M-18.51M-14.91M1.14M18.62M-12.32M-6.01M
Preferred Dividend Payments 0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M
Net Income towards Common Stockholders -16.94M-25.59M-26.20M-20.53M-18.00M-14.61M-17.75M-15.90M-22.79M-10.91M-1.60M17.70M-13.31M-6.33M
Additional items
EPS (Basic) -0.20-0.29-0.29-14.25-2.78-2.10-2.38-2.20-2.62-1.19-0.171.28-0.74-0.29
EPS (Weighted Average and Diluted) -0.29-0.29-14.25-2.78-2.10-2.38-2.20-2.62-1.19-0.020.34-0.74-0.29
Shares Outstanding (Weighted Average) 86.34M86.96M89.76M5.94M6.47M6.96M7.46M7.23M8.69M9.15M9.67M13.88M18.08M21.55M
Shares Outstanding (Diluted Average) 86.96M89.76M5.94M6.47M6.96M7.46M7.23M8.69M9.15M65.29M52.50M54.27M21.55M
EBITDA -19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M
Interest Expenses 0.52M0.53M0.23M0.18M0.23M0.16M0.02M0.02M0.01M0.01M0.03M0.03M0.01M